158 related articles for article (PubMed ID: 6239722)
1. Impaired lymphocyte and suppressor cell function in minimal change nephropathy, membranous nephropathy and focal glomerulosclerosis.
Taube D; Brown Z; Williams DG
Clin Nephrol; 1984 Oct; 22(4):176-82. PubMed ID: 6239722
[TBL] [Abstract][Full Text] [Related]
2. Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome.
Taube D; Chapman S; Brown Z; Williams DG
Clin Nephrol; 1981 Jun; 15(6):286-90. PubMed ID: 7249426
[TBL] [Abstract][Full Text] [Related]
3. T cell subsets in glomerulonephritis.
Lin CY; Yang YM; Fu YK
Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
[TBL] [Abstract][Full Text] [Related]
4. Changing trends of histopathology in childhood nephrotic syndrome in western Saudi Arabia.
Kari JA
Saudi Med J; 2002 Mar; 23(3):317-21. PubMed ID: 11938425
[TBL] [Abstract][Full Text] [Related]
5. Incidence of nephrotic syndrome in patients with glomerulonephritis.
Sonkodi S; Tichy B; Mágori A; Ormos J
Acta Med Hung; 1986; 43(3):311-3. PubMed ID: 3588169
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
7. A chemotactic inhibitory factor in the minimal change nephrotic syndrome.
Lin CY; Su SN
Int J Pediatr Nephrol; 1986; 7(4):191-6. PubMed ID: 3818178
[TBL] [Abstract][Full Text] [Related]
8. [Two-color analysis of lymphocyte subpopulations in membranous nephropathy and minimal change nephrotic syndrome].
Ozaki T
Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):797-806. PubMed ID: 2593316
[TBL] [Abstract][Full Text] [Related]
9. Minimal change glomerulonephritis and focal glomerulosclerosis markers and 'in vitro' activity of peripheral blood mononuclear cell.
Dall'Aglio P; Chizzolini C; Brigati C
Proc Eur Dial Transplant Assoc; 1983; 19():673-8. PubMed ID: 6348758
[TBL] [Abstract][Full Text] [Related]
10. Impaired lymphocyte transformation in minimal change nephropathy in remission.
Chapman S; Taube D; Brown Z; Williams DG
Clin Nephrol; 1982 Jul; 18(1):34-8. PubMed ID: 7116703
[TBL] [Abstract][Full Text] [Related]
11. [The nephrotic syndrome caused by minimal lesions nephropathy and focal glomerulosclerosis. Morphological and clinical aspects].
Barbiano Di Belgiojoso G; Bertoli S; Busnach G; Casanova S; Dal Col A; Confalonieri R; Galato R; Micoli G; Surian M; Minetti L
Minerva Nefrol; 1981; 28(3):403-14. PubMed ID: 7329618
[No Abstract] [Full Text] [Related]
12. [Pathogenesis of immune glomerulonephritis].
Rougier JP; Ronco P
Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
[TBL] [Abstract][Full Text] [Related]
13. Minimal change nephropathy and focal segmental glomerulosclerosis.
Mallick NP; Brenchley PE; Webb NJ
Kidney Int Suppl; 1997 Mar; 58():S80-2. PubMed ID: 9067951
[No Abstract] [Full Text] [Related]
14. IgG subclass composition of monomeric and polymeric IgG in the serum of patients with nephrotic syndrome.
Aro M; Hardwicke J
Clin Nephrol; 1984 Nov; 22(5):244-52. PubMed ID: 6518674
[TBL] [Abstract][Full Text] [Related]
15. Cell mediated immunity in idiopathic glomerulonephritis.
Sasdelli M; Cagnoli L; Candi P; Mandreoli M; Beltrandi E; Zucchelli P
Clin Exp Immunol; 1981 Oct; 46(1):27-34. PubMed ID: 6978215
[TBL] [Abstract][Full Text] [Related]
16. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
[TBL] [Abstract][Full Text] [Related]
17. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
18. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
Voznesenskaia TS; Sergeeva TV
Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479
[TBL] [Abstract][Full Text] [Related]
19. Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).
Kondo S; Yoshizawa N; Kusumi Y; Takeuchi A; Torikata C
Clin Nephrol; 1999 Nov; 52(5):278-84. PubMed ID: 10584990
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
